Kopp Family Office’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
B
NAMI
Kopp Family Office's NEO Position: Q4 2025 in Review
Kopp Family Office sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 463,860 shares — an estimated $3.58M sold.
Kopp Family Office first reported a position in NEO in Q4 2019 and held it in 24 quarters. The position peaked at $166M in Q4 2020. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.
- Kopp Family Office reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
- Kopp Family Office sold 463,860 NeoGenomics shares in Q4 2025, an estimated $3.58M.
- Kopp Family Office first reported a position in NeoGenomics in Q4 2019 and held it in 24 quarters.
- Kopp Family Office's NeoGenomics position peaked at $166M in Q4 2020.
- 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.
Based on Kopp Family Office's 13F filing for Q4 2025, filed 12 Jan 2026.